Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Insight Molecular Diagnostics Inc., formerly Oncocyte Corporation, is a molecular diagnostics technology company. The Company's technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is in the process of rebranding its VitaGraft assay (also known as VitaGraft Kidney), which is a lab developed test, under the name GraftAssureCore. The Company's transplant products include GraftAssureCore, GraftAssureDx, GraftAssureIQ. Its oncology products include DetermaCNI, DetermaIO, and OncoTIME. GraftAssureCore is a clinical blood-based solid organ transplantation monitoring test. GraftAssureIQ is a research use only (RUO) blood-based solid organ transplantation monitoring test. DetermaIO is a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. DetermaCNI is a blood-based monitoring tool for monitoring therapeutic efficacy in cancer patients. OncoTIME enables research on the tumor immune microenvironment.
Find out what a historical investment in Insight Molecular Diagnostics Inc would be worth today using our IMDX stock calculator.
Buying IMDX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Insight Molecular Diagnostics Inc in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in IMDX
What is the ticker symbol of Insight Molecular Diagnostics Inc?
The ticker symbol for Insight Molecular Diagnostics Inc is IMDX.
How much is one share of IMDX?
One share of IMDX is valued at $1.66 as of 20 November 2026.
What is the market capitalisation of Insight Molecular Diagnostics Inc IMDX?
As of 20 November 2026 Insight Molecular Diagnostics Inc has a market cap of $52.08M.
What is the 52-week high for Insight Molecular Diagnostics Inc stock?
The Insight Molecular Diagnostics Inc 52-week high stock price is $7.51.
What is the 52-week low for Insight Molecular Diagnostics Inc stock?
The Insight Molecular Diagnostics Inc 52-week low stock price is $1.50.
Can I buy IMDX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy IMDX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in IMDX on Stake
Buy IMDX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of IMDX from only US$10 with fractional shares